is associated with lower adiposity and a reduced number of metabolic disturbances (MetD).
arlier research had focused on skeletal disorders associated with vitamin D deficiency including rickets in children (1) and osteomalacia (2) or osteoporosis (3) in adults, the risk of which can be modified by increasing intake of foods enriched with vitamin D (4) . However, recent evidence points to the fact that vitamin D status, particularly in plasma, may also be protective against the risk of cardiovascular disease (5-7), cancer (8 -10) , and infection (11) (12) (13) . As in rickets and osteomalacia, vitamin D dietary supplementation has been shown to prevent the adverse effects of insufficiency and reduce the risk of some of those disorders as well as that of all-cause mortality (14 -16) . A number of recent studies have shown that higher levels of 25-hydroxyvitamin D [25(OH)D] in plasma are associated with lower adiposity (mainly measured by anthropometric measures) and a reduced number of metabolic disturbances (MetD) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) .
Moreover, obesity and its related disorders were shown to be inversely related to overall dietary quality (34 -39) , specifically the dairy component of dietary quality, which is a rich source of vitamin D (40 -42) . However, no recent large nationally representative U.S. study has addressed the question of whether the effects of 25(OH)D on percent body fat (%BF) and obesity-related MetD differ appreciably between subjects with central obesity (CO ϩ ) compared with those without central obesity (CO Ϫ ), although a few earlier studies had restricted their samples to morbidly obese subjects (19) . A significantly stronger effect on a select group of people who may be prone to MetD (e.g. CO ϩ ) may implicate gene-environment interactions. In fact, using the National Health and Nutrition Examination Surveys (NHANES) 1988 -1994 and 1999 -2004 data (43) , we found that waist circumference increased at a faster pace in the upper percentiles than the lower percentiles in the U.S. adult population. This may suggest an interaction between environmental changes and genetic makeup. In fact, one candidate gene (vitamin D receptor gene polymorphism) was recently shown to be significantly related to obesity status in general and waist circumference value in particular (44, 45) . Moreover, there is a lack of understanding of the role played by dietary quality (an environmental factor) in these associations. Finally, elevated C-reactive protein (CRP) and hyperuricemia, which often accompany obesity and the metabolic syndrome (46 -49) and have been associated with poor dietary quality (50, 51) , have not been studied thus far in relation to 25(OH)D status in the general U.S. population. The present study aims to tackle these research gaps and examine a pathway between dietary quality and the number of MetD going through 25(OH)D and adiposity, stratifying the study sample by central obesity status.
Materials and Methods

Database and study subjects
The NHANES is a series of cross-sectional annual surveys that have provided health and nutrition data on nationally representative samples of the U.S. civilian population since the 1970s. NHANES has a stratified, multistage probability cluster sampling design. In-home interviews collecting basic sociodemographic data are followed by health examinations in a mobile examination center (MEC) that include various anthropometric, blood pressure, and laboratory measurements. Detailed descriptions of the study design and data collection have been published elsewhere (52) .
In the present study, NHANES data from adults aged 20 -85 yr for the periods 2001-2002 and 2003-2004 were merged. Among a sample of 9769 subjects (4661 men and 5108 women) with complete demographic data, we excluded pregnant and lactating women. Of the remaining sample (n ϭ 9050; eligible sample 1; see Fig. 1 ), 8579 had complete dietary data and 8155 had complete 25(OH)D status and dietary data. Many metabolic outcomes considered had missing data ranging from 10 -20% of this sample, including anthropometric measurements such as waist circumference for assessment of central obesity status. However, because fasting blood sample tests [e.g. fasting blood glucose, insulin, high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG)] were conducted in only half of the eligible adult sample, complete data on all MetD disturbances combined and other variables of interest were available for only 1943 subjects (eligible sample 4; see Fig. 1.) . Sampling weights were applied to account for nonresponse bias.
Outcome assessment
%BF
Whole-body %BF was calculated as total body fat mass divided by total mass (fat mass ϩ lean mass ϩ total bone mineral content) ϫ 100. All these measurements were obtained by per- forming a whole-body scan using dual-energy x-ray absorptiometry (DXA) and a multiple detector fan-beam Hologic QDR-2000 densitometer (Hologic, Inc., Waltham, MA) (53) .
MetD
Blood pressure and laboratory tests. Using a mercury sphygmomanometer, three to four blood pressure determinations [systolic blood pressure (SBP) and diastolic blood pressure (DBP)] were made during MEC examinations and during home examinations for older participants (54) . Final measures were the average of three determinations. SBP and DBP values were also combined as mean arterial pressure (MAP): MAP ϭ (SBP ϩ 2 ϫ DBP)/3.
Specimen collection and processing instructions are detailed elsewhere (55) . In brief, fasting blood glucose was analyzed by reacting glucose with ATP, a reaction that is catalyzed by the enzyme hexokinase. TG were measured enzymatically by hydrolyzing to produce glycerol in a series of coupled reactions. HDL-C was measured using two methods: 1) heparin-manganese precipitation and 2) direct immunoassay. Fasting serum insulin was measured using a RIA reagent (Pharmacia Diagnostics, Uppsala, Sweden). Uric acid level was measured by oxidization with the specific enzyme uricase to form allantoin and H 2 O 2 (Hitachi model 737 multichannel analyzer; Roche Molecular Biochemicals Diagnostics, Indianapolis, IN), and high-sensitivity CRP was quantified by latex-enhanced nephelometry (Behring Diagnostics, Westwood, MA).
MetD assessment.
Although most of the analysis examined continuous measures of MetD, summary measures combining binary outcomes with prespecified cutoff points were also considered. These binary outcomes included the nonadiposity components of the metabolic syndrome, as defined by the National Cholesterol Education Program, Adult Treatment Panel III (NCEP ATP III) (56): 1) SBP/DBP at least 130/85 mm Hg, 2) fasting glucose at least 110 mg/dl, 3) TG at least 150 mg/dl, and 4) HDL-C less than 40 mg/dl for men and less than 50 mg/dl for women. Additionally, we examined the following: 5) the homeostatic model assessment of insulin resistance (HOMA-IR) with a cutoff point of 2.61 reflecting high insulin resistance level as suggested elsewhere (57, 58), 6) hyperuricemia with cutoffs of more than 7 mg/dl in men and more than 6 mg/dl in women (59), and 7) elevated CRP defined as more than 2.11 mg/liter (60) . One index (Index I) summing the NCEP ATP III binary MetD (i.e. criteria 1-4; 0 ϭ no; 1 ϭ yes) and all other disturbances (i.e. criteria 5-7) and thus ranging between 0 and 7, was examined as a measure of overall MetD. (61) and includes energy-adjusted components. Twelve components are estimated with varying ranges, and the total score (HEI total ; sum of the 12 components) may range from 0 -100, with a higher score indicating a better quality diet (61) . Components of the HEI (HEI k , where k ϭ 1-12), particularly HEI 7 (dairy), were also considered.
Exposure assessment
Vitamin D status
Dietary intake and dietary quality
Covariates
Sociodemographic covariates
Age, sex, race/ethnicity [categorized as non-Hispanic (NH) Whites, non-Hispanic Blacks, Mexican-American, and other groups], education (grouped as 0, less than a high school education; 1, high school (12 yr); and 2, more than a high school education) and family income (poverty income ratio Ͻ 125% for poor, 125-300% for near poor, and Ͼ300% for not poor).
Physical activity
Three measures of physical activity (PA) were included as covariates: 1) vigorous activity over the past 30 d that was dichotomized as 1 ϭ yes and 0 ϭ no; 2) PA compared with age peers, coded as 0 ϭ less, 1 ϭ about the same, and 2 ϭ more; 3) a more objective measure, the MET ϫ hours per week of PA (62, 63) , constructed based on individual leisure-time activities and categorized in part of the analysis as 0 to less than 5, 5-10, and more than 10.
Central obesity status
Waist circumference (in centimeters) was measured using a tape measure starting from the hip bone and wrapping around the waist at the level of the navel. Central obesity was defined as waist circumference more than 102 cm for men and more than 88 cm for women, based on the North American Association for the Study of Obesity/National Heart, Lung, and Blood Institute recommendations (64) .
Statistical analysis
All analyses except for structural equations modeling (SM) were conducted using Stata release 10.0 (Stata Corp., College Station, TX). Using survey commands, we applied recommended subsample weights for the period of 2001-2004 and accounted for multiple imputations for DXA scan data. MEC exam weights were used for most analyses, except for those where the fasting half-sample had the limiting variable in the analysis, in which case a specific weight variable was substituted to obtain population estimates of means, proportions, and regression coefficients. Masked variance units were used to estimate variances using the Taylor series linearization method. This allowed us to provide an unbiased estimate for the SE, given sampling design complexity (65) .
Our analysis consisted of several steps. First, we described the sample participants' characteristics by selected meaningful categories of 25(OH)D levels (Ͻ20, 20 to Ͻ25, and Ն25) and central obesity status. Associations between variables were tested using ANOVA (non-design-based F test) with continuous outcomes and a design-based F test for categorical outcomes.
Second, a set of multiple linear regression models with continuous 25(OH)D as the main outcome and central obesity as the main exposure was conducted to assess the confounding effects of sociodemographic, lifestyle, and dietary factors as well as that of %BF in the main association. Attenuation of the main association was of particular interest.
Third, multiple linear regression models with continuous %BF, selected MetD, and ordinal MetD (Indices I and II) as outcomes were conducted to test their associations with overall dietary quality (HEI total ; standardized z-score) and 25(OH)D status (also as z-score) as explanatory variables in the model, controlling for potential confounders and stratifying by central obesity status. Effect modification by central obesity status was tested by adding an exposure ϫ central obesity interaction term to each model. Design-based Wald tests were used to assess significance of regression coefficients. A sensitivity analysis for MetD was conducted whereby %BF was added as an additional potential confounder in each model. A type I error of 0.05 was used for significance and 0.10 for borderline significance.
Finally, using the CALIS procedure (66) in SAS version 9.2, we fit SM to test the most likely pathway between dietary quality and number of binary MetD (Index I), considering 25(OH)D and %BF as serial mediators. Global goodness of SM fit indices included the root mean square error of approximation (RMSEA) with its 90% confidence interval (CI) (criterion is 0.06 or lower for good fit), goodness of fit index adjusted for degrees of freedom (AGFI), which ranges between 0 (poor fit) and 1 (model fits). Full models were reduced by removing nonsignificant exogenous variables with a 0.10 type I error. Effect modification by central obesity status was determined for the main associations of interest by comparing 95% CI of path coefficients (see Fig. 2 for more details). Findings were interpreted in terms of significance of the direct effects of HEI total and HEI dairy on Index I and the significance of path coefficients pertaining to the indirect effect through 25(OH)D and %BF. Lack of significance of a direct effect may indicate that mediation is pseudo-complete in the pathway being tested, as long as the mediating path coefficients are statistically significant at type I error of 0.05. In contrast, the significance of direct effect at a type I error of 0.05 may suggest that an alternative pathway is at play. 
Results
The prevalence of hypovitaminosis D [25(OH)D
where HEI (total or dairy component; z-score) was allowed to predict all subsequent outcomes, plasma 25(OH)D level (vitamin D; z-score) was allowed to predict only %BF and number of MetD (Index I; ordinal), and BF was allowed to predict only MetD. Z j is the vector of other exogenous variables (e.g. sociodemographic and lifestyle factors; continuous terms such as age were entered as continuous), whereas e 1 , e 2, e 3 , and e 4 are the error terms. Correlations between all exogenous variables except error terms (assumed to be zero) were estimated. Table 4 , with nonoverlapping 95% CI between the two groups.
Discussion
The present study is, to our knowledge, the first to examine the complex relationships among 25(OH)D, dietary quality, %BF, and MetD in a nationally representative sample of U.S. adults, stratifying by central obesity status. Our study had several key findings. We found a stronger inverse association of 25(OH)D with those MetD among the CO ϩ compared with the CO Ϫ participants, which is indicated by a significant interaction between 25(OH)D and central obesity in predicting %BF, fasting blood glucose, HOMA-IR, CRP, and total disturbances as measured by NCEP criteria and all other criteria (Index I). Second, we found that 25(OH)D was positively associated with overall dietary quality (measured by HEI) and showed a linear dose response with the dairy component of HEI among the CO Ϫ and CO ϩ groups. U.S. adults with OLS models controlled for age (years, grouped), sex, education (dummies for high school and more than high school), poverty income ratio (dummies for near poor and not poor), race/ethnicity (dummies for non-Hispanic Black, Mexican-American, and others), categorical metabolic equivalent tasks ϫ hours per week, and two other measures of PA (vigorous and activity compared with others). In all models, the main effects of 25(OH)D and HEI total were also entered. For 25 (OH)D, 1 SD corresponded to 9.43 ng/ml (see Table 1 footnote for conversion to SI units); 1 SD of HEI total corresponded to 13.12 points. HOMA-IR is the product of the fasting values of glucose (G 0 , expressed as millimoles per liter) and insulin (I 0 , expressed as microunits per milliliter); HOMA-IR ϭ (I 0 ϫ G 0 )/22.5. a Sample sizes for model 1a were as follows: HOMA-IR (n ϭ 1672); uric acid (n ϭ 3457); CRP (n ϭ 3471); Index I (n ϭ 898). Sample sizes for model 1b were as follows: HOMA-IR (n ϭ 1902); uric acid (n ϭ 3808); CRP (n ϭ 3820); Index I (n ϭ 898). Sample sizes for models 1c and 1d were the sum of sample sizes for models 1a and 1b for each outcome.
central obesity had lower 25(OH)D, higher %BF, and increased average MetD. Moreover, based on SM, the main pathway between HEI dairy and Index I involved predominant mediation by 25(OH)D followed by %BF among the CO Ϫ group and a nonsignificant direct association between HEI dairy and %BF or Index I as well as the lack of a direct association between 25(OH)D and Index I. Among the CO ϩ group, however, 25(OH)D had a significant direct inverse association with Index I in addition to its indirect inverse association with %BF, which in turn was positively associated with Index I. Moreover, HEI dairy had a direct inverse association with Index I that was independent of 25(OH)D and %BF.
Findings from a number of previous epidemiological studies indicate a protective role of 25(OH)D against various metabolic disorders and metabolic syndrome. Several studies reported that 25(OH)D was inversely related to %BF (17, 29) , to elevated blood pressure (20, 21, 23, 30, 31, 33) , elevated glucose or insulin resistance (22, 26, 28, 31, 33) , and TG (23) and positively associated with HDL-C (22). In particular, studies using NHANES III (1988 -1994) (26, 28 -30, 33) have consistently found those associations among U.S. adults. Moreover, one recent study using NHANES 2003-2004 found an inverse relationship with NCEP ATP III-defined metabolic syndrome (25) . This finding was replicated in other populations (19) . Furthermore, both overall dietary quality and dairy intake were shown to be independent dietary factors that were inversely associated with adiposity (35, 38, 39) and many MetD (34, 40, 41) as well as with the metabolic syndrome (34, 40, 41) . One recent randomized controlled clinical trial found that vitamin D supplementation did not affect adiposity but had a significant effect on other metabolic disturbances in the desired direction, including TG and inflammatory markers such as TNF-␣. However, it was positively associated with increased low-density lipoprotein-cholesterol among others, and thus, additional trials are indicated to ascertain the general beneficial effect of vitamin D supplementation (67) . Thus, these earlier findings are in line with ours, although none of the previous studies had examined effect modification by central obesity status.
The biological mechanism by which vitamin D may influence the metabolic syndrome has not been completely Table 1 footnote for conversion to SI units); 1 SD of HEI total corresponded to 13.12 points. HEI dairy , %BF, and Index I were entered as is. b P Ͻ 0.05 for null hypothesis that path coefficient ␣ ϭ 0.
elucidated. Nevertheless, there is accumulating evidence from clinical and experimental studies suggesting that decreased vitamin D is related to insulin resistance (68), a hallmark characteristic of the metabolic syndrome in general and central obesity in particular. Adequate vitamin D status has been linked to enhanced biosynthetic capacity of pancreatic ␤-cells and the conversion of proinsulin to insulin. These notions are further supported by the fact that pancreatic ␤-cells and several classical target organs for insulin action express vitamin D receptors (69, 70) and the 1␣-hydroxylase enzyme, required to convert 25(OH)D to its active form (71, 72) . Our study observed that the protective effects of vitamin D on the various MetD (including insulin resistance as measured by HOMA-IR) seem to be stronger among the CO ϩ group
[who had lower serum 25(OH)D levels] compared with the CO Ϫ group. These differences might be attributed to polymorphisms in the VDR gene that need to be explored in future genetic studies.
To explain the adiposity (%BF or central obesity status) vs. serum 25(OH)D inverse association, it was hypothesized that obesity status is associated with less bioavailability of the fat-soluble vitamin D, by its sequestration into excessive fat tissues (73) . Furthermore, a high incidence of secondary hyperparathyroidism regulated by serum 1,25-dihydroxyvitamin D levels have been reported in obese subjects (74) . These increased levels of active vitamin D may be responsible for a negative feedback inhibition of hepatic 25(OH)D synthesis (74) , although the opposite was found in more recent studies (75, 76) . Moreover, some investigators have demonstrated that increased intracellular calcium, which is regulated by vitamin D and inversely related to dairy consumption, was responsible for stimulating lipogenesis and suppression of lipolysis (77) . It is also possible that the lactose, protein, and fat in dairy foods may enhance satiety and reduce the risk of obesity, particularly central adiposity, relative to other high-carbohydrate foods and beverages (78) .
In addition, 1,25-dihydroxyvitamin D, the active form of vitamin D3, is known to down-regulate the renin-angiotensin system (79), which itself plays an important role in hypertension as well as the development of insulin resistance. For the former effect, there is evidence that activation of the renal calcium receptors leads to increased prostaglandin E 2 synthesis with subsequent natriuresis and blood pressure-lowering effects (80) . The latter effect is mediated by various pathways in the insulin signaling cascade including the insulin receptor, the insulin receptor substrate, and phosphatidylinositol 3-kinase (81) .
Finally, we have observed in our SM that among the CO ϩ group, the intake of dairy products as measured by HEI dairy has a direct negative association with MetD (Index I) independently of 25(OH)D or %BF. This alternative pathway is likely due to additional bioactive compounds in dairy products for which CO ϩ subjects may be more in need of than the CO Ϫ group, and these substances do not raise vitamin D and do not necessarily affect adiposity. The exact nature of these compounds is yet to be determined. Our study had a number of strengths. First, it is a population-based large nationally representative study with ethnic diversity taken into account. Second, it used DXA scan measures to estimate %BF using standard radiological techniques. Third, the assay for 25(OH)D measurement is of high accuracy and had a coefficient of variation of less than 10%.
Despite its strengths, our study had several limitations. First, it is based on cross-sectional data and thus cannot test causality. It is possible that obese people, including CO ϩ patients, may have modified their lifestyles including diet and outdoors activities, which may contribute to their lower level of 25(OH)D than their CO Ϫ counterparts.
DXA scans were less accurate at higher body mass index levels, in part due to truncal adiposity, and older persons were more likely to be excluded for DXA scans in general than their younger counterparts (82) . Second, dietary intake was assessed using a single 24-h recall that may not be a good reflection of usual intake. In addition, intake of vitamin D was not readily available, and dairy consumption as measured by HEI dairy was considered as a proxy. Fourth, timing of blood sample collection and differences in latitude may have affected the distribution of serum 25(OH)D levels the measurement of which may be overestimated, because the antibody also recognizes 24,25-dihydroxyvitamin D, which includes 10 -15% of the 25(OH)D value. Finally, the NHANES data does not control for seasonal influence on serum 25(OH)D levels, despite our efforts to adjust for sunlight exposure by various proxy measures of PA.
In conclusion, we found that among U.S. adults, a higher 25(OH)D was associated with higher HEI, lower %BF, and lower MetD. Furthermore, the 25(OH)D-%BF and 25(OH)D-MetD inverse associations were stronger among U.S. adults with central obesity. Finally, the pathway linking HEI (dairy consumption in particular) to MetD through 25 
